Sino Biopharmaceutical Revenue

In the year 2024, Sino Biopharmaceutical had annual revenue of 28.87B CNY with 10.18% growth. Sino Biopharmaceutical had revenue of 12.99B in the half year ending December 31, 2024.

Revenue

28.87B CNY

Revenue Growth

+14.93%

P/S Ratio

3.71

Revenue / Employee

1.18M CNY

Employees

24,379

Market Cap

113.93B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	28.87B	2.67B	10.18%
Dec 31, 2023	26.20B	173.25M	0.67%
Dec 31, 2022	26.03B	-835.19M	-3.11%
Dec 31, 2021	26.86B	3.21B	13.59%
Dec 31, 2020	23.65B	-586.81M	-2.42%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
BeOne Medicines	32.49B
Hansoh Pharmaceutical Group Company	13.05B
Innovent Biologics	10.03B
JD Health International	61.89B
WuXi Biologics	19.87B
Akeso	2.26B
CSPC Pharmaceutical Group	28.99B
Sichuan Kelun-Biotech Biopharmaceutical	2.06B

Revenue Rankings

Sino Biopharmaceutical News

4 weeks ago - Hong Kong stocks waver on China’s mixed economic data - South China Morning Post
4 weeks ago - Hong Kong stocks fall slightly on rising geopolitical tensions - South China Morning Post
10 months ago - Sino Biopharmaceutical Limited goes ex-dividend tomorrow - Seeking Alpha
1 year ago - Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln - Reuters
4 years ago - Chinese Company Gets FDA Approval For Drug To Fight Chemotherapy Nausea - Forbes
4 years ago - Week In Review: JD Health Raises $3.5 Billion In Hong Kong IPO, Climbs 56% On First Day - Seeking Alpha

More News